MIST SCHEDULE 13G/A: SEC filing
Milestone Pharmaceuticals Inc.
Filed with the SEC on · accession 0001969764-26-000002
Milestone Pharmaceuticals Inc. (MIST) filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 20, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -7.1% by the first close after the filing.
Summary of the filing
Propel Bio Management, LLC and related reporting persons filed an amended Schedule 13G disclosing beneficial ownership of approximately 10.1% of Milestone Pharmaceuticals' common stock, with sole voting and dispositive power over 12,615,010 shares.
Key details
How MIST stock reacted
Close before
$0.40
Nov 19, 2026
First close after
-7.06%
$0.37
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for MIST, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MIST?
Click hereFrequently asked questions
What did MIST file with the SEC on Nov 20, 2026?
MIST filed a SCHEDULE 13G/A (SEC filing). Propel Bio Management, LLC and related reporting persons filed an amended Schedule 13G disclosing beneficial ownership of approximately 10.1% of Milestone Pharmaceuticals' common stock, with sole voting and dispositive power over 12,615,010 shares.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did MIST stock react to this filing?
MIST closed at $0.40 before the filing and $0.37 on Nov 20, 2026 (-7.06%).
Other MIST SEC filings
Get alerts when MIST files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days